About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Shankar Lal Rampal Dye-Chem Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
22-Aug-2025
30-Aug-2025
Final Dividend & A.G.M.
18-Jul-2025
28-Jul-2025
Quarterly Results
08-May-2025
19-May-2025
Audited Results
04-Feb-2025
14-Feb-2025
Quarterly Results
05-Nov-2024
14-Nov-2024
Quarterly Results
08-Aug-2024
14-Aug-2024
Quarterly Results & Final Dividend & A.G.M.
15-May-2024
23-May-2024
Audited Results
07-Feb-2024
14-Feb-2024
Quarterly Results
06-Nov-2023
10-Nov-2023
Quarterly Results
07-Aug-2023
14-Aug-2023
Quarterly Results & Final Dividend & A.G.M.
23-May-2023
30-May-2023
Audited Results
01-Feb-2023
14-Feb-2023
Quarterly Results
04-Nov-2022
14-Nov-2022
Quarterly Results (Revised)
03-Aug-2022
13-Aug-2022
A.G.M. & Final Dividend & Quarterly Results & Inter alia, to consider: (i) Approval of Board Report and allied report for FY 2021-22; this is in continuance to outcome of Board meeting dated 28/05/2022. (ii) Fixing date of Annual General Meeting, approving the notice and authorizing Director/Company Secretary to issue such Notice. (iii) Noting of various disclosures under SEBI Regulations, Companies Act and other applicable w.r.t. Previous year and Current Year. (iv) the recommendation of Final Dividend for the financial year 2021-22; if any and the same will be subject to approval of shareholders in Annual General Meeting. (v) Any other matter, as considered necessary by the chairman.
23-May-2022
28-May-2022
Increase in Authorised Capital & Bonus issue & Audited Results
07-Feb-2022
14-Feb-2022
Quarterly Results Inter alia, (ii) To consider and approve the CSR Project/s(including previous approved) as approved by CSR Committee in their meetings. (iii) To consider and take note of decisions of all committees and approval to transcript of previous General Meeting. (iv) To consider any other matters with the permission of the Chair.
14-Dec-2021
20-Dec-2021
Bonus issue
01-Nov-2021
09-Nov-2021
Increase in Authorised Capital & Bonus issue & Quarterly Results Inter alia, to consider and approve : (i) To Consider and approve the Unaudited Financial Results of the Company along with allied report/review report of the Statutory Auditor; for the quarter (Q2) and half year ended on 30th September, 2021. (ii) Proposal to Increase Authorised Share Capital of the Company. (iii) Proposal for Declaration of Bonus Issue of Equity Shares. (iv) Fixing date of Extra Ordinary General Meeting, approving the notice and authorizing Director/Company Secretary to issue such Notice. (v) Any other matter, as considered necessary.
05-Aug-2021
11-Aug-2021
Quarterly Results
22-Jun-2021
30-Jun-2021
Final Dividend & Audited Results & A.G.M.
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.